Tasso Announces SOC 2 Type 2 Compliance Certification

Completion of SOC 2 Type 2 audit certifies Tasso platforms as trusted and secure

 

SEATTLE – October 27, 2023 – Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the successful completion of the System and Organization Controls (SOC) 2 Type 2 audit. The SOC 2 Type 2 audit is conducted by independent auditors to determine whether a company is maintaining a high standard for handling sensitive client data through its operations, controls, and processes. The auditors observed Tasso’s operations against all five SOC 2 Trust Services Criteria (Security, Availability, Processing Integrity, Confidentiality, and Privacy) and found no exceptions. This achievement demonstrates Tasso’s ability to securely manage client data and highlights the company’s commitment to meeting the highest industry standards.

The SOC 2 Type 2 audit, which assesses the organization's controls over time, was completed in September of 2023. The audit was conducted by Prescient Assurance, a leader in security testing and compliance certifications for SaaS companies worldwide.

Tasso provides a variety of end-to-end blood collection logistics services as part of its Tasso Care™ solutions platform. Achieving SOC 2 Type 2 compliance, the industry gold standard, ensures that client data is safe and secure.

“This SOC 2 Type 2 compliance certification is an important milestone for Tasso,” said Ben Casavant, PhD, CEO and Co-Founder of Tasso. “Patient health and other sensitive data is critical to safeguard. Our SOC 2 report reemphasizes the security and privacy of our platform, and our commitment to protecting client data.”

 

 

About Tasso

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.

 

Media Contact

Dina Schneider

(206) 822-4186 x1016

media@tassoinc.com

Previous
Previous

Randox Health First to Offer Tasso’s Patient-Centric Remote Sampling Device

Next
Next

Tasso, Inc. Announces Monica Williams as Chief Financial Officer